Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulpegfilgrastim for Neutropenia Prevention in NDMM
NCT07018271Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Cytokines & Interferons
01
Overview
Open-label, single-arm trial of pegteograstim in neutropenia and Infection, sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of infection during oncological treatment at 6 months. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
pegteograstim
03
Conditions
neutropeniaInfection
Beyond the preview
Go deeper on NCT07018271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07018271.